Iantrek specializes in ophthalmic devices and technology. The new financing will be used for clinical introduction and further studies of Iantrek’s micro-interventional glaucoma surgical devices, according to an Aug. 30 Iantrek news release.
“There remains a significant unmet clinical need to provide safe and effective micro-interventional tools for aqueous outflow management,” said Sean Ianchulev, MD, founder of Iantrek. “We are grateful to have a world-class syndicate of investors supporting our efforts to advance these new technologies. With two commercially ready MIGS platforms, Iantrek is uniquely positioned to transform the horizon of micro-interventional ophthalmic surgery.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
